Envestnet Asset Management
VIR icon

Envestnet Asset Management’s Vir Biotechnology VIR Stock Holding History

Envestnet Asset Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-51,827
Closed -$1.27M – 4168
2023
Q2 		$1.27M Sell
51,827
-292,517
-85% -$7.35M ﹤0.01% 2568
2023
Q1 		$1.05M Buy
344,344
+294,390
+589% +$7.53M ﹤0.01% 2642
2022
Q4 		$1.26M Buy
49,954
+4,733
+10% +$116K ﹤0.01% 2470
2022
Q3 		$872K Buy
45,221
+36,373
+411% +$925K ﹤0.01% 2680
2022
Q2 		$225K Buy
+8,848
New +$207K ﹤0.01% 3516
2022
Q1 		– Sell
-6,839
Closed -$286K – 4070
2021
Q4 		$286K Buy
+6,839
New +$268K ﹤0.01% 3450

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return